Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Pervasive muscle response monitoring for everyone, a physiotherapy revolution

Descrizione del progetto

Prodotti innovativi che si dimostrano promettenti per il trattamento del dolore cronico

Il progetto MDURANCE, finanziato dall’UE, sta sviluppando un prodotto diagnostico per i disturbi muscoloscheletrici in grado di analizzare rapidamente i dati complessi provenienti da sensori elettromiografici non invasivi e di presentarli in un formato comprensibile. L’analisi elettromiografica consente di visualizzare l’attività elettrica dei muscoli scheletrici e identificare con precisione la funzionalità muscolare. Il prodotto presenta un’elaborazione unica dei dati, viene eseguito sul cloud e può generare risultati nell’arco di cinque minuti grazie a economici sensori elettromiografici. Portare questa forma di analisi del paziente all’interno di cliniche standard di fisioterapia comporterà una diagnosi dei disturbi muscoloscheletrici molto più rapida, nonché esercizi e processi di riabilitazione adeguatamente prescritti e monitorati.

Obiettivo

Almost all of us have suffered a Musculoskeletal disorder (MSD) of some type or another. Whilst for several of us a back, or
neck ache can go with minor intervention, for many the problem can be chronic. Home life becomes a daily struggle, work
can not be completed and lively hoods are ruined.
At mDurance we have been developing a product that can rapidly analyse the complex data from non-invasive EMG
(Electromyographic) sensors and present this to physiotherapists in an understandable format. EMG analysis allows
visualisation of the electrical activity of the skeletal muscles in order to precisely pin-point which muscles are performing as
they should and which are not. Current solutions that attempt to do this needed custom adaptation to each patient and
situation, useful results take upto 45 minutes to generate and the costs are prohibitive for the overwhelming majority of
physiotherapists.
Based on the result of several years of research work and various scientific papers, mDurance has unique data processing
that generates results within 5minutes. Running in the cloud and using low-cost EMG sensors we are aiming to drive uptake
of this form of patient analysis to standard physiotherapist clinics. The result will be much faster MSD diagnosis and properly
targeted and monitored rehabilitation exercises and processes. Additionally, we also target Hospitals and other organisations
assessing the capacity of workers, as well as the sports market where we can increment athlete performance, better protect
against injury and decrease rehabilitation times.
The market is vast. There are over 1 million physiotherapy specialists worldwide and around 200,000 Health & Wellbeing
Centres plus professional and high performance sport clubs together worldwide. With a dedicated go-to-market plan, we aim
to take a 0.75% market share growing to 22 employees by 2023 and a total revenue of 10.76M Euros.

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-EIC-SMEInst-2018-2020

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

MDURANCE SOLUTIONS SOCIEDAD LIMITAD
Contributo netto dell'UE
€ 50 000,00
Indirizzo
CL VIDRIOS DE SAN LAZARO 3 ESC.C 4-B
18012 Granada
Spagna
PMI
Sì
Regione
Sur Andalucía Granada
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00